A carregar...
Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia
Clinical trials have demonstrated that some patients with chronic myeloid leukemia (CML) treated for several years with tyrosine kinase inhibitors (TKIs) who have maintained a molecular response can successfully discontinue treatment without relapsing. Treatment free remission (TFR) can be reached b...
Na minha lista:
| Publicado no: | World J Clin Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7769711/ https://ncbi.nlm.nih.gov/pubmed/33437662 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v11.i12.996 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|